Form D · Pharmaceuticals
TINAD, LLC
Lincolnshire, IL · CIK 0001621239
Offering snapshot reported Oct 2, 2014 · SEC filing
- Reported sold
- $600K Offering amount: $600K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Sep 17, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 2, 2014 | Initial | $600,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Security to be acquired
- Exemptions
- 06b, 04.3
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-225650
Source: Form D, filed Oct 2, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Mandel | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
10 Queens Way
Lincolnshire, IL, 60069
Lincolnshire, IL, 60069